These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3531678)

  • 1. Cell culture approaches to the analysis of glomerular inflammation.
    Lovett DH; Sterzel RB
    Kidney Int; 1986 Aug; 30(2):246-54. PubMed ID: 3531678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential fatty acid deficiency depletes rat glomeruli of resident macrophages and inhibits angiotensin II-induced eicosanoid synthesis.
    Lefkowith JB; Schreiner G
    J Clin Invest; 1987 Oct; 80(4):947-56. PubMed ID: 3116045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine networks and the pathogenesis of glomerulonephritis.
    Johnson RJ
    J Lab Clin Med; 1993 Feb; 121(2):190-2. PubMed ID: 8433031
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute glomerular upregulation of ornithine decarboxylase is not essential for mesangial cell proliferation and matrix expansion in anti-Thy-1-nephritis.
    Ketteler M; Westenfeld R; Gawlik A; de Heer E; Distler A
    Nephrol Dial Transplant; 2000 Jan; 15(1):16-22. PubMed ID: 10607762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential role of inflammatory and fibrogenic cytokines in the glomerular diseases.
    Ortiz A; Gómez-Chiarri M; Alonso J; Bustos C; Gómez-Guerrero C; López-Armada MJ; Gómez-Garre D; Palacios I; Ruíz-Ortega M; Gutierrez S
    J Lipid Mediat Cell Signal; 1994 Feb; 9(1):55-74. PubMed ID: 8032716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombospondin-2 therapy ameliorates experimental glomerulonephritis via inhibition of cell proliferation, inflammation, and TGF-beta activation.
    Daniel C; Wagner A; Hohenstein B; Hugo C
    Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1299-309. PubMed ID: 19726547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The participation of platelet-activating factor and cytokines in the pathogenesis of glomerular damage].
    Egido J; Gómez-Chiarri M; Lerma JL; González E; Maestre C; Ortiz A; Hernando L
    Rev Clin Esp; 1990; 187(3):137-43. PubMed ID: 2284487
    [No Abstract]   [Full Text] [Related]  

  • 8. The long pentraxin PTX3 is synthesized in IgA glomerulonephritis and activates mesangial cells.
    Bussolati B; Peri G; Salvidio G; Verzola D; Mantovani A; Camussi G
    J Immunol; 2003 Feb; 170(3):1466-72. PubMed ID: 12538709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet activating factor (PAF) as a mediator of injury in nephrotoxic nephritis.
    Bertani T; Livio M; Macconi D; Morigi M; Bisogno G; Patrono C; Remuzzi G
    Kidney Int; 1987 Jun; 31(6):1248-56. PubMed ID: 3039232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis in progressive crescentic glomerulonephritis.
    Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
    Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta and glomerulonephritis: anti-inflammatory versus prosclerotic actions.
    Kitamura M; Sütö TS
    Nephrol Dial Transplant; 1997 Apr; 12(4):669-79. PubMed ID: 9140992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular remodelling after inflammatory injury.
    Savill J; Johnson RJ
    Exp Nephrol; 1995; 3(3):149-58. PubMed ID: 7620853
    [No Abstract]   [Full Text] [Related]  

  • 13. [Glomerulonephritis and cytokines].
    Koide H
    Nihon Jinzo Gakkai Shi; 1994 Mar; 36(3):183-93. PubMed ID: 7910863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cytokines and growth factors in glomerulonephritis: a chance for future therapeutic intervention.
    Johnson RJ
    Nephron; 1996; 73(4):506-14. PubMed ID: 8856243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexpression of a novel glomerular basement membrane matrix material in mesangial cell culture and glomerulosclerosis.
    Yang AH; Wang JS
    Exp Mol Pathol; 1995 Apr; 62(2):83-98. PubMed ID: 8549699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of growth factor midkine exacerbates necrotizing glomerular injuries in progressive glomerulonephritis.
    Kojima H; Kosugi T; Sato W; Sato Y; Maeda K; Kato N; Kato K; Inaba S; Ishimoto T; Tsuboi N; Matsuo S; Maruyama S; Yuzawa Y; Kadomatsu K
    Am J Pathol; 2013 Feb; 182(2):410-9. PubMed ID: 23201132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory mechanism in glomerular mesangial cell proliferation.
    Haas CS; Schöcklmann HO; Lang S; Kralewski M; Sterzel RB
    J Nephrol; 1999; 12(6):405-15. PubMed ID: 10626832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The significance of eicosanoids in glomerular diseases].
    Stahl RA
    Klin Wochenschr; 1986 Sep; 64(18):813-23. PubMed ID: 3022060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of glomerular damage in glomerulonephritis.
    Couser WG
    Nephrol Dial Transplant; 1998; 13 Suppl 1():10-5. PubMed ID: 9507491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibronectin (FN) decreases glomerular lesions and synthesis of tumour necrosis factor-alpha (TNF-alpha), platelet-activating factor (PAF) and FN in proliferative glomerulonephritis.
    Ortíz A; Alonso J; Gómez-Chiarri M; Lerma JL; Seron D; Condom E; González E; Egido J
    Clin Exp Immunol; 1995 Aug; 101(2):334-40. PubMed ID: 7648718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.